Financial Performance - The company's main business revenue for 2023 was CNY 21.486 billion, a decrease of 7.10% year-on-year[17]. - The company's operating revenue for 2023 was ¥7,581,887,642.68, a decrease of 1.96% compared to ¥7,733,670,622.91 in 2022[29]. - Operating costs decreased to ¥5,329,106,326.49, down 8.66% from ¥5,835,342,734.89 in the previous year[29]. - The net profit attributable to shareholders was not explicitly stated, but the total comprehensive income for the year was ¥566,682,541.00[35]. - The total comprehensive income for the year 2023 amounted to CNY 1,319,570,529.98[41]. - The company reported a net loss of CNY 505,765,614.76 for the year[41]. Revenue Sources - Revenue from viscose staple fiber was CNY 9.127 billion, from soda ash was CNY 7.720 billion, from PVC resin was CNY 2.179 billion, from caustic soda was CNY 1.300 billion, and from dimethyl silicone mixed ring was CNY 0.903 billion[17]. Assets and Liabilities - As of December 31, 2023, the total current assets decreased to ¥7,807,387,370.65 from ¥10,313,414,318.18 in 2022, representing a decline of approximately 24.3%[21]. - Total liabilities decreased to ¥10,626,377,711.64 from ¥13,030,972,674.41, a decline of about 18.5%[23]. - Total equity increased to ¥14,966,228,884.94 from ¥14,575,611,238.78, an increase of about 2.7%[23]. - The company's retained earnings rose to ¥7,024,447,945.19 from ¥6,901,580,126.06, reflecting an increase of approximately 1.8%[23]. Cash Flow - The company's cash flow from operating activities was CNY 60,854,134.02 for the year[40]. - The net cash flow from investing activities was -321,949,406.48, compared to -399,008,487.39 in the previous period, indicating an improvement[56]. - Cash inflow from financing activities totaled 4,211,074,910.03, down from 5,440,958,657.24 in the previous period[56]. - The total cash and cash equivalents at the end of the period were 2,834,438,464.16, down from 4,336,289,011.65 at the beginning of the period[56]. Shareholder Information - The company plans to distribute a cash dividend of 0.83 RMB per share for the fiscal year 2023, amounting to a total of 171,341,004.18 RMB, which represents 30.29% of the net profit attributable to shareholders[191]. - The total share capital of the company as of December 31, 2023, is 2,064,349,448 shares, which will be the basis for the dividend distribution[191]. Corporate Governance - The company had a total of 8 board meetings this year, with all directors attending in person[189]. - The company has a total of 4 shareholder meetings, with all directors present[189]. - The company has independent directors, including Zhao Xiangdong and Lu Gui, who attended all meetings[189]. - The company has a strong focus on financial management and corporate governance, with multiple experts in key positions[188]. Research and Development - The company implemented over 200 R&D projects in 2023, including the development of "ultra-low salt soda ash technology" and achieved international advanced levels in three new technologies and products[171]. - The company has a strategic focus on enhancing its R&D capabilities to drive innovation and competitiveness in the market[30]. - The company has a significant focus on research and development to enhance its product offerings and technological capabilities[68]. Market Strategy - The company plans to continue expanding its market presence and investing in new technologies and products[30]. - The company aims to enhance its resource control capabilities and innovation R&D capabilities, aligning with the new development philosophy of innovation, coordination, green, openness, and sharing[178]. - The company is committed to becoming a leading enterprise in the salt chemical and new chemical materials fields along the coastal economic belt of Hebei Province[178]. Financial Management - The company reported a total owner's equity of 8,778,896,098.90, with an increase of 1,113,894,599.28 during the year[63]. - The company has recognized government subsidies as deferred income, which will be amortized over the useful life of the related assets[169]. - The company recognizes expected credit losses based on historical credit loss experience, current conditions, and forecasts of future economic conditions[79].

唐山三友化工股份有限公司 独立董事述职报告 （赵向东） 本人赵向东作为唐山三友化工股份有限公司（以下简称"公司"）独立董事， 在 2023 年度严格按照《公司法》《上市公司独立董事管理办法》《上市公司治理 准则》等法律法规、规范性文件以及《公司章程》的规定和要求，认真、勤勉、 独立的履行职责，积极出席相关会议，认真审议董事会各项议案，充分发挥了独 立董事及各专门委员会委员的作用，切实维护了公司和全体股东的利益。现将本 人 2023 年度履行独立董事职责情况汇报如下： 一、基本情况 （一）出席董事会及股东大会情况 2023 年度，公司共召开 8 次董事会会议，4 次股东大会。任职期内，本人按 时出席公司以上会议，认真审阅各项议案，充分发表自己的意见和建议，客观、 独立行使表决权，对各项议案均投了赞成票，没有提出异议。报告期内，本人出 席公司董事会和股东大会情况如下： | 应参加 | 现场出席 | 以通讯方 | 委托出席 | 缺席董 | 是否连续两次 | 出席股 | | --- | --- | --- | --- | --- | --- | --- | | 董事会 | 董事会次 | 式出席董 | 董事会次 | 事 ...

唐山三友化工股份有限公司 独立董事述职报告 （卢桂） 本人卢桂作为唐山三友化工股份有限公司（以下简称"公司"）独立董事，在 2023 年度严格按照《公司法》《上市公司独立董事管理办法》《上市公司治理准 则》等法律法规、规范性文件以及《公司章程》的规定和要求，认真、勤勉、独 立的履行职责，积极出席相关会议，认真审议董事会各项议案，充分发挥了独立 董事及各专门委员会委员的作用，切实维护了公司和全体股东的利益。现将本人 2023 年度履行独立董事职责情况汇报如下： 一、基本情况 卢桂，女，博士研究生学历，中共党员，回族。现任中央民族大学法学院教 学科研岗位讲师、北京市东卫律师事务所兼职律师。2023 年 8 月起任公司独立 董事。 报告期内，本人作为公司独立董事任职符合《上市公司独立董事管理办法》 第六条规定的独立性要求，不存在影响独立性的情况。 二、独立董事年度履职概况 （一）出席董事会及股东大会情况 2023 年度，公司共召开 8 次董事会会议，4 次股东大会。任职期内，本人按 时出席公司以上会议，认真审阅各项议案，充分发表自己的意见和建议，客观、 独立行使表决权，对各项议案均投了赞成票，没有提出异议。报告期内 ...

证券代码：600409 证券简称：三友化工 公告编号：临 2024-015 号 三、公司主要原材料的价格变动情况 二、公司主要产品的价格变动情况 | | 2023 年 | 2023 年 | | 2022 年 | | | --- | --- | --- | --- | --- | --- | | 主要产品 名称 | 第四季度 | 第三季度 | | 第四季度 | | | | 平均售价 | 平均售价 | 环比价格 | 平均售价 | 同比价格 | | | （元/吨） | （元/吨） | 变动幅度 | （元/吨） | 变动幅度 | | 纯碱 | 2,330.54 | 2,049.81 | 13.70% | 2,391.33 | -2.54% | | 粘胶短纤维 | 12,189.60 | 12,082.55 | 0.89% | 12,490.23 | -2.41% | | 烧碱 | 2,879.92 | 2,502.67 | 15.07% | 3,323.04 | -13.33% | | PVC | 5,424.99 | 5,479.92 | -1.00% | 5,546.52 | -2.19% | | 二甲基硅氧 烷 ...

公司代码：600409 公司简称：三友化工 唐山三友化工股份有限公司 2023 年度内部控制评价报告 唐山三友化工股份有限公司全体股东： 根据《企业内部控制基本规范》及其配套指引的规定和其他内部控制监管要求（以下简称企业内部 控制规范体系），结合本公司（以下简称公司）内部控制制度和评价办法，在内部控制日常监督和专项 监督的基础上，我们对公司2023年12月31日（内部控制评价报告基准日）的内部控制有效性进行了评价。 一. 重要声明 按照企业内部控制规范体系的规定，建立健全和有效实施内部控制，评价其有效性，并如实披露内 部控制评价报告是公司董事会的责任。监事会对董事会建立和实施内部控制进行监督。经理层负责组织 领导企业内部控制的日常运行。公司董事会、监事会及董事、监事、高级管理人员保证本报告内容不存 在任何虚假记载、误导性陈述或重大遗漏，并对报告内容的真实性、准确性和完整性承担个别及连带法 律责任。 公司内部控制的目标是合理保证经营管理合法合规、资产安全、财务报告及相关信息真实完整，提 高经营效率和效果，促进实现发展战略。由于内部控制存在的固有局限性，故仅能为实现上述目标提供 合理保证。此外，由于情况的变化可能 ...

证券代码：600409 证券简称：三友化工 公告编号：临 2024-020 号 唐山三友化工股份有限公司 关于日常关联交易 2023 年完成情况及 2024 年预计的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●是否需要提交股东大会审议：否 ●日常关联交易对上市公司的影响：公司发生的日常关联交易是与公司日常 生产、经营相关的交易，各项关联交易的定价政策严格遵循公开、公平、公正、 等价有偿的一般商业原则，不存在损害公司和股东权益的情形。上述交易的发生 不会对公司持续经营能力、盈利能力及资产独立性等产生重大不利影响，亦不会 因本次关联交易额度的预计而对关联方形成依赖。 一、日常关联交易基本情况 （一）日常关联交易履行的审议程序 2024 年 4 月 11 日，公司独立董事专门会议审议通过了《关于日常关联交易 2023 年完成情况及 2024 年预计的议案》，全体独立董事一致认为：公司 2023 年 日常关联交易实际完成没有超出年度预计总额，各项关联交易定价严格遵循公 开、公平、公正、等价有偿的一般商业原则 ...

唐山三友化工股份有限公司 董事会审计委员会对会计师事务所履行监督职责情况报告 根据《中华人民共和国公司法》《中华人民共和国证券法》《上 市公司治理准则》《国有企业、上市公司选聘会计师事务所管理办法》 《上海证券交易所上市公司自律监管指引第 1 号——规范运作》和唐 山三友化工股份有限公司（以下简称"公司"）《公司章程》《董事会审 计委员工作细则》等规定和要求，董事会审计委员会本着勤勉尽责的 原则，恪尽职守，认真履职。现将董事会审计委员会对会计师事务所 2023 年度履行监督职责的情况汇报告如下： 一、2023 年年审会计师事务所基本情况 经审计，中喜会计师事务所认为公司财务报表在所有重大方面 按照企业会计准则的规定编制，公允反映了公司截至2023年12 月 31 日的合并及母公司财务状况以及 2023 年度的合并及母公司经营成 果和现金流量；公司按照《企业内部控制基本规范》和相关规定在所 有方面保持了有效的财务报告内部控制。中喜会计师事务所出具了标 准无保留意见的审计报告。 在执行审计工作的过程中，中喜会计师事务所就会计师事务所 和相关审计人员的独立性、审计工作小组的人员构成、审计计划、风 险判断、风险及舞弊 ...

证券代码：600409 证券简称：三友化工 公告编号：临 2024-024 号 唐山三友化工股份有限公司 关于会计政策变更的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、本次会计政策变更概述 本次变更前，公司对原材料核算采用计划成本法核算，日常收发原材料均按 计划成本价计价，月末再通过对原材料成本差异的计算，将发出和结存原材料的 计划成本还原为实际成本。 为进一步提高公司管理水平，加强成本核算的精细化管理，公司自 2024 年 1 月 1 日起将原材料核算方法由计划成本法改为实际成本法，并按照会计准则相 关要求编制 2024 年 1 月 1 日及以后期间财务报表。 本次变更后，公司采用实际成本法，原材料按照取得时的实际成本计价，发 出和结存也按实际成本计价，不再结转材料成本差异。 二、本次会计政策变更履行的决策程序 本次会计政策变更属于公司自主变更，《关于会计政策变更的议案》已经公 司董事会审计委员会全体同意并提交董事会审议。2024 年 4 月 25 日，公司分别 召开九届四次董事会、九届四次监事 ...

关于唐山三友化工股份有限公司 非经营性资金占用及其他关联资金往来情况 汇总表的专项审计报告 目 录 1、 专项审计报告 中喜会计师事务所（特殊普通合伙） 您可使用手机"扫一扫"或进入"注册会计师行业绩——哈密录在 | | 地址： 北京市东城区崇文门外大街11 号新成文化大厦 A 座 11 层 邮编： 100062 电话:010-67085873 传真: 010-67084147 邮箱:zhongxi@zhongxicpa.net 2、 附表 委托单位：唐山三友化工股份有限公司 审计单位：中喜会计师事务所（特殊普通合伙） 联系电话：010-67085873 关于唐山三友化工股份有限公司 非经营性资金占用及其他关联资金往来情况的 专项说明 中喜专审 2024Z00405 号 中喜会计师事务所(特殊普通合伙) ZHONGXI CPAs (SPECIAL GENERAL PARTNERSHIP) 关于对唐山三友化工股份有限公司 非经营性资金占用及其他关联资金往来情况的专项说明 中喜专审2024Z00405号 唐山三友化工股份有限公司全体股东: 我们接受委托,审计了唐山三友化工股份有限公司(以下简称三友化工)2023 ...

Financial Performance - The net profit attributable to shareholders of the listed company decreased due to slow recovery in downstream demand and new production capacity release, despite efforts to control costs[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was impacted by the decline in prices of raw materials such as coal and silicon, leading to a total cost expense decrease compared to the previous year[5]. - The basic earnings per share decreased significantly, with the decline rate exceeding that of operating revenue[5]. - The diluted earnings per share increased year-on-year, indicating a positive trend in shareholder returns despite overall profit challenges[5]. - The company's total revenue for Q1 2024 was CNY 1,790,844,275.50, a decrease of 10.3% compared to CNY 1,995,446,665.11 in Q1 2023[21]. - The company's operating revenue for the first quarter of 2024 was CNY 5,215,908,562.37, representing a decrease of 4.45% compared to the same period last year[34]. - The net profit attributable to the parent company for Q1 2024 was CNY 140,501,471.67, compared to CNY 3,770,203.74 in Q1 2023, indicating a significant increase in profitability[24]. - The net profit for the period was RMB 140,472,674.01, significantly up from RMB 5,426,850.93 in the previous period, indicating a substantial improvement[52]. - The net profit for the period was 127,231,644.81, compared to 172,925,236.19 in the previous year, showing a decrease of about 26.38%[59]. Cash Flow - The net cash flow from operating activities decreased by 102.04%, attributed to a reduction in cash received from sales and an increase in tax payments[5]. - The company's cash flow from operating activities in Q1 2024 was CNY 3,479,503,522.85, a decrease from CNY 3,611,129,775.59 in Q1 2023[24]. - The net cash flow from operating activities was -1,113,840.36, a decrease from 54,718,862.14 in the previous period[54]. - Net cash flow from operating activities decreased to $62.47 million from $312.16 million, a decline of approximately 80% year-over-year[60]. - The net cash flow from financing activities was -$450.59 million, an improvement from -$678.91 million year-over-year[60]. Assets and Liabilities - Total current assets as of March 31, 2024, were approximately CNY 7.74 billion, a slight decrease from CNY 7.81 billion at the end of 2023[11]. - Total assets of the company as of March 31, 2024, were CNY 14,248,047,726.44, down from CNY 14,570,291,596.75 at the end of 2023[20]. - The total liabilities decreased to approximately CNY 10.47 billion from CNY 10.63 billion, indicating improved financial stability[14]. - The total liabilities decreased from CNY 3,200,000,000 to CNY 3,000,000,000, indicating a reduction in financial obligations[20]. - The total liabilities amounted to 4,227,996,055.13, down from 4,677,500,898.57, indicating a reduction of about 9.56%[57]. Shareholder Equity - The total equity attributable to shareholders increased to approximately CNY 13.64 billion from CNY 13.55 billion, showing a positive trend in shareholder value[14]. - The equity attributable to shareholders of the listed company increased to CNY 13,635,556,708.67, marking a growth of 0.61% compared to the previous year[40]. - The total equity increased to 10,020,051,671.31 from 9,892,790,698.18, reflecting an increase of approximately 1.30%[57]. Cost Management - The company continues to focus on cost reduction and efficiency improvement strategies to mitigate external market pressures[5]. - Operating costs for Q1 2024 were CNY 1,366,052,751.49, down from CNY 1,468,398,796.72 in Q1 2023, reflecting a cost reduction of approximately 7%[21]. - The total operating costs for the period were RMB 5,031,092,578.52, a decrease of 7.4% compared to RMB 5,432,990,746.82 in the previous period[52]. Research and Development - Research and development expenses for Q1 2024 were CNY 34,466,473.09, an increase of 12.4% compared to CNY 30,565,841.94 in Q1 2023[21]. - The company's research and development expenses amounted to RMB 136,257,063.15, an increase from RMB 126,899,086.69 in the previous period, reflecting ongoing investment in innovation[52]. Market Strategy - The company plans to expand its market presence and invest in new technologies to drive future growth[21].